Telix Pharmaceuticals

Oncology One, located in Melbourne, is dedicated to advancing cancer therapies by uniting experts in biotechnology to develop small molecule drug programs aimed at addressing unmet clinical needs, including those in pediatric and rare cancers. The organization leverages a team of respected leaders in medical research, clinical practice, and commercialization to create impactful cancer treatments. The management team is comprised of distinguished professionals, including Professor Shelley Dolan, who leads the Peter MacCallum Cancer Centre, and Dr. Ian Street, a pioneer in small molecule drug discovery. Together, they foster innovation and collaboration within the cancer research community to accelerate the development of novel therapeutics. Generated from the website

Gertrude Biomedical, located in Parkville, Victoria, is a private biotechnology company focused on developing innovative oncology therapeutics, particularly small molecule inhibitors targeting transcription factors. Their mission is to create transformative cancer solutions, aiming to block the mechanisms of cancer growth and spread for patients with untreatable cancers. The company emphasizes its commitment to "druggable the undruggable," leveraging expertise in medicinal chemistry and drug development to address significant unmet medical needs. Currently, their primary focus is on the transcription factor SOX18, which holds considerable clinical and commercial potential in regulating gene pathways to combat multiple hallmark features of cancer. Generated from the website